The collaboration brings two companies with market-leading expertise together. Optiscan has the experience in high-resolution endomicroscopic imaging technology and Mayo Clinic is considered a leader in the field of robotic surgery and clinical care.
Optiscan Imaging chief executive officer and managing director Dr Camile Farah said: “We are thrilled with the outcomes delivered to date from our collaboration with the Mayo Clinic. Just twelve months on from Optiscan signing a Know-How agreement with this prestigious US medical care organisation, both groups have materially progressed an imaging system for use in robotic surgery.”
To date, progress has been made in three important areas. Optiscan engineers and clinical staff have worked with a leading Mayo Clinic breast surgeon to better understand robotic-assisted surgical workflows and the optimal way to include endomicroscopic imaging systems into various surgical scenarios.
The two firms have set out to identify standalone imaging systems’ hardware and software requirements that can provide the maximum level of autonomy from robotic surgical systems, while also proving capable of integrating with as many systems as possible.
Work to create prototypes of imaging probe accessories remains a priority for the partners who are aiming to develop a range of instruments capable of cutting, grasping and retracting. Preclinical testing on the accessory prototypes will get underway before being assessed in a preclinical setting.
The Mayo Clinic is the world’s biggest integrated, not-for-profit medical group practice, which has a mission aimed at turning medical research into earlier diagnoses and new cures.
The robotic-assisted surgery market is experiencing significant growth and is expected to be driven further by technological advancements.
Is your ASX-listed company doing something interesting? Contact: mattbirney@bullsnbears.com.au
- For more: Elrisala website and for social networking, you can follow us on Facebook
- Source of information and images “brisbanetimes”“
